Evidence map›Paper›PMID 35089160›Full record

ArticleJournal of medical Internet research2022

Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings.

Paméla Voillot, Brigitte Riche, Michel Portafax, Pierre Foulquié, Anaïs Gedik, Sébastien Barbarot, Laurent Misery, Stéphane Héas, Adel Mebarki, Nathalie Texier and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Exploring online discussions for those living with cutaneous T cell lymphoma: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Paméla VoillotKap Code, Paris, France.ORCID 0000-0001-7156-9075
Brigitte RicheSanofi Genzyme, Gentilly, France.ORCID 0000-0003-3742-6817
Michel PortafaxSanofi Genzyme, Gentilly, France.ORCID 0000-0001-8612-5565
Pierre FoulquiéKap Code, Paris, France.ORCID 0000-0003-4485-0835
Anaïs GedikKap Code, Paris, France.ORCID 0000-0003-1284-5433
Sébastien BarbarotCentre Hospitalier Universitaire de Nantes, Nantes, France.ORCID 0000-0002-6629-9100
Laurent MiseryCentre Hospitalier Universitaire de Brest, Brest, France.ORCID 0000-0001-8088-7059
Stéphane HéasUniversité de Rennes 2, Rennes, France.ORCID 0000-0002-4817-1429
Adel MebarkiKap Code, Paris, France.ORCID 0000-0002-2925-7585
Nathalie TexierKap Code, Paris, France.ORCID 0000-0003-3749-254X
Stéphane SchückKap Code, Paris, France.ORCID 0000-0003-2642-7726
Sanofi (France) · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire de Nantes · FRUniversité Rennes 2 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtopic dermatitis (AD) is a chronic, pruritic, inflammatory disease that occurs most frequently in children but also affects many adults. Social media have become key tools for finding and disseminating medical information.

objectiveThe aims of this study were to identify the main themes of discussion, the difficulties encountered by patients with respect to AD, the impact of the pathology on quality of life (QoL; physical, psychological, social, or financial), and to study the perception of patients regarding their treatment.

methodsA retrospective study was carried out by collecting social media posts in French language written by internet users mentioning their experience with AD, their QoL, and their treatments. Messages related to AD discomfort posted between July 1, 2010, and October 23, 2020, were extracted from French-speaking publicly available online forums. Automatic and manual extractions were implemented to create a general corpus and 2 subcorpuses depending on the level of control of the disease.

resultsA total of 33,115 messages associated with AD were included in the analysis corpus after extraction and cleaning. These messages were posted by 15,857 separate web users, most of them being women younger than 40 years. Tips to manage AD and everyday hygiene/treatments were among the most discussed topics for controlled AD subcorpus, while baby-related topics and therapeutic failure were among the most discussed topics for insufficiently controlled AD subcorpus. QoL was discussed in both subcorpuses with a higher proportion in the controlled AD subcorpus. Treatments and their perception were also discussed by web users.

conclusionsMore than just emotional or peer support, patients with AD turn to online forums to discuss their health. Our findings show the need for an intersection between social media and health care and the importance of developing new approaches such as the Atopic Dermatitis Control Tool, which is a patient-related disease severity assessment tool focused on patients with AD.

Indexed as

Dermatitis, AtopicSocial MediaAdultChildFemaleHumansQuality of LifeRetrospective StudiesSeverity of Illness Indexatopic dermatitisAtopic Dermatitis Control Tooldermatologyhealth carehealth-related quality of lifeonline healthonline health informationreal worldskin diseasesocial mediasocial media use

Identifiers

PMID35089160
PMCPMC8838596
OpenAlexW3214780111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.